Nagy JA - Search Results

1

Antiangiogenic properties of gold nanoparticles.

Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S. Mukherjee P, et al. Among authors: nagy ja. Clin Cancer Res. 2005 May 1;11(9):3530-4. doi: 10.1158/1078-0432.CCR-04-2482. Clin Cancer Res. 2005. PMID: 15867256

2

Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis.

Basu S, Sarkar C, Chakroborty D, Nagy J, Mitra RB, Dasgupta PS, Mukhopadhyay D. Basu S, et al. Cancer Res. 2004 Aug 15;64(16):5551-5. doi: 10.1158/0008-5472.CAN-04-1600. Cancer Res. 2004. PMID: 15313889

3

Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin.

Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D, Dvorak AM, Dvorak HF, Puder M, Mukhopadhyay D, Folkman J. Satchi-Fainaro R, et al. Among authors: nagy ja. Cancer Cell. 2005 Mar;7(3):251-61. doi: 10.1016/j.ccr.2005.02.007. Cancer Cell. 2005. PMID: 15766663 Free article.

4

Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.

Mukhopadhyay D, Nagy JA, Manseau EJ, Dvorak HF. Mukhopadhyay D, et al. Among authors: nagy ja. Cancer Res. 1998 Mar 15;58(6):1278-84. Cancer Res. 1998. PMID: 9515816

5

The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.

Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D. Basu S, et al. Among authors: nagy ja. Nat Med. 2001 May;7(5):569-74. doi: 10.1038/87895. Nat Med. 2001. PMID: 11329058

6

Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.

Pal S, Iruela-Arispe ML, Harvey VS, Zeng H, Nagy JA, Dvorak HF, Mukhopadhyay D. Pal S, et al. Among authors: nagy ja. Microvasc Res. 2000 Sep;60(2):112-20. doi: 10.1006/mvre.2000.2246. Microvasc Res. 2000. PMID: 10964585

7

The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis.

Shih SC, Zukauskas A, Li D, Liu G, Ang LH, Nagy JA, Brown LF, Dvorak HF. Shih SC, et al. Among authors: nagy ja. Cancer Res. 2009 Apr 15;69(8):3272-7. doi: 10.1158/0008-5472.CAN-08-4886. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351819 Free PMC article.

8

VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation.

Chang SH, Kanasaki K, Gocheva V, Blum G, Harper J, Moses MA, Shih SC, Nagy JA, Joyce J, Bogyo M, Kalluri R, Dvorak HF. Chang SH, et al. Among authors: nagy ja. Cancer Res. 2009 May 15;69(10):4537-44. doi: 10.1158/0008-5472.CAN-08-4539. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435903 Free PMC article.

9

Anti-VEGF/VEGFR therapy for cancer: reassessing the target.

Sitohy B, Nagy JA, Dvorak HF. Sitohy B, et al. Among authors: nagy ja. Cancer Res. 2012 Apr 15;72(8):1909-14. doi: 10.1158/0008-5472.CAN-11-3406. Cancer Res. 2012. PMID: 22508695 Free PMC article. Review.

10

Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy.

Sitohy B, Nagy JA, Jaminet SC, Dvorak HF. Sitohy B, et al. Among authors: nagy ja. Cancer Res. 2011 Nov 15;71(22):7021-8. doi: 10.1158/0008-5472.CAN-11-1693. Epub 2011 Sep 21. Cancer Res. 2011. PMID: 21937680 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters